HK Stock Market Move | Brain-computer interface concept stocks rise in the morning National Medical Products Administration meeting on the promotion of brain-computer interface medical devices held in Beijing.
Brain-machine interface concept stocks rose in the morning session. As of the time of writing, Nanjing Panda (00553) rose by 4.16% to 4.51 Hong Kong dollars; Microport Neuro- medtchnology (02172) rose by 4.24% to 10.83 Hong Kong dollars; and Brain Polar Aurora-B (06681) rose by 2.58% to 5.96 Hong Kong dollars.
The concept stocks of brain-machine interface rose in the morning session, as of the time of writing, Nanjing Panda Electronics (00553) rose 4.16% to HK$4.51; MICROPORT NEURO (02172) rose 4.24% to HK$10.83; BRAINAURORA-B (06681) rose 2.58% to HK$5.96.
On the news front, the National Medical Products Administration held a Brain-Machine Interface Medical Device Work Promotion Conference in Beijing on December 18. The meeting called for a deep implementation of the spirit of the Fourth Plenary Session of the 20th Central Committee of the Communist Party of China, a profound understanding of the important strategic significance of brain-machine interfaces as a forward-looking layout for future industries; adherence to safety and effectiveness as the primary premise, innovative evaluation and supervision methods, construction of standard systems, strengthening of technical guidance services; strengthening cross-department cooperation, joining hands with industry, academia, research, and medical professionals to jointly solve key technical issues, improve the industrial chain and supply chain; implementation of corporate responsibilities, problem-oriented, enhancement of product reliability and overall competitiveness, actively promote brain-machine interface devices to better and faster serve clinical practice and benefit patients.
Guotai Haitong pointed out that with technological innovation breakthroughs, policy support guidance, capital investment and other driving factors, the brain-machine interface industry is expected to usher in important development opportunities, and is expected to see demand release in downstream markets such as medical health and consumer life, with promising market prospects.
Related Articles

Merck & Co., Inc. (MRK.US), Bristol-Myers Squibb (BMY.US) and several other pharmaceutical companies have agreed to lower drug prices in the United States in exchange for tariff exemptions and policy support from the Trump administration.

NVIDIA Corporation (NVDA.US) relative to the semiconductor index is at a ten-year low in valuation! Bernstein says that buying at this time will yield an average return rate of over 150%.
.png)
With Tesla, Inc. (TSLA.US) CEO Musk having a close relationship, it is rumored that Morgan Stanley may lead SpaceX's epic IPO.
Merck & Co., Inc. (MRK.US), Bristol-Myers Squibb (BMY.US) and several other pharmaceutical companies have agreed to lower drug prices in the United States in exchange for tariff exemptions and policy support from the Trump administration.

NVIDIA Corporation (NVDA.US) relative to the semiconductor index is at a ten-year low in valuation! Bernstein says that buying at this time will yield an average return rate of over 150%.

With Tesla, Inc. (TSLA.US) CEO Musk having a close relationship, it is rumored that Morgan Stanley may lead SpaceX's epic IPO.
.png)





